{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:15:57Z","timestamp":1784664957848,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004361","name":"Krebsliga Schweiz","doi-asserted-by":"crossref","award":["KFS-3692-08-2015"],"award-info":[{"award-number":["KFS-3692-08-2015"]}],"id":[{"id":"10.13039\/501100004361","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004361","name":"Krebsliga Schweiz","doi-asserted-by":"crossref","award":["KFS-3692-08-2015"],"award-info":[{"award-number":["KFS-3692-08-2015"]}],"id":[{"id":"10.13039\/501100004361","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004361","name":"Krebsliga Schweiz","doi-asserted-by":"crossref","award":["KFS-3692-08-2015"],"award-info":[{"award-number":["KFS-3692-08-2015"]}],"id":[{"id":"10.13039\/501100004361","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["Ha2103\/10-1"],"award-info":[{"award-number":["Ha2103\/10-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["Ha2103\/10-1"],"award-info":[{"award-number":["Ha2103\/10-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"crossref","award":["31003A_175637"],"award-info":[{"award-number":["31003A_175637"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Myoglobin (MB) is expressed in different cancer types and may act as a tumor suppressor in breast cancer. The mechanisms by which basal MB expression level impacts murine mammary tumorigenesis are unclear. We investigated how MB expression in breast cancer influences proliferation, metastasis, tumor hypoxia, and chemotherapy treatment in vivo<jats:italic>.<\/jats:italic> We crossed PyMT and WapCreTrp53<jats:sup>flox<\/jats:sup> mammary cancer mouse models that differed in tumor grade\/type and onset of mammary carcinoma with MB knockout mice. The loss of MB in WapCre;Trp53<jats:sup>flox<\/jats:sup> mice did not affect tumor development and progression. On the other hand, loss of MB decreased tumor growth and increased tissue hypoxia as well as the number of lung metastases in PyMT mice. Furthermore, Doxorubicin therapy prevented the stronger metastatic propensity of MB-deficient tumors in PyMT mice. This suggests that, although MB expression predicts improved prognosis in breast cancer patients, MB-deficient tumors may still respond well to first-line therapies. We propose that determining the expression level of MB in malignant breast cancer biopsies will improve tumor stratification, outcome prediction, and personalized therapy in cancer patients.\n<\/jats:p>","DOI":"10.1038\/s41598-023-34614-w","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T11:39:38Z","timestamp":1683718778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Endogenous myoglobin expression in mouse models of mammary carcinoma reduces hypoxia and metastasis in PyMT mice"],"prefix":"10.1038","volume":"13","author":[{"given":"Mostafa A.","family":"Aboouf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Armbruster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Guscetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Thiersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Boss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"G\u00f6decke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Winning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Padberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Fandrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"Kristiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hankeln","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Gassmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Gorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"issue":"Pt 12","key":"34614_CR1","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1242\/jeb.00243","volume":"206","author":"JB Wittenberg","year":"2003","unstructured":"Wittenberg, J. B. & Wittenberg, B. A. Myoglobin function reassessed. J. Exp. Biol. 206(Pt 12), 2011\u20132020 (2003).","journal-title":"J. Exp. Biol."},{"issue":"1","key":"34614_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2353\/ajpath.2009.081124","volume":"175","author":"SE Flonta","year":"2009","unstructured":"Flonta, S. E., Arena, S., Pisacane, A., Michieli, P. & Bardelli, A. Expression and functional regulation of myoglobin in epithelial cancers. Am. J. Pathol. 175(1), 201\u2013206 (2009).","journal-title":"Am. J. Pathol."},{"issue":"12","key":"34614_CR3","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1038\/sj.bjc.6605702","volume":"102","author":"G Kristiansen","year":"2010","unstructured":"Kristiansen, G. et al. Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype. Br. J. Cancer 102(12), 1736\u20131745 (2010).","journal-title":"Br. J. Cancer"},{"issue":"12","key":"34614_CR4","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.21873\/anticanres.11217","volume":"36","author":"S Meller","year":"2016","unstructured":"Meller, S. et al. Ectopic myoglobin expression is associated with a favourable outcome in head and neck squamous cell carcinoma patients. Anticancer Res. 36(12), 6235\u20136241 (2016).","journal-title":"Anticancer Res."},{"issue":"4","key":"34614_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00428-014-1646-y","volume":"465","author":"S Meller","year":"2014","unstructured":"Meller, S. et al. Myoglobin expression in prostate cancer is correlated to androgen receptor expression and markers of tumor hypoxia. Virchows Arch. 465(4), 419\u2013427 (2014).","journal-title":"Virchows Arch."},{"issue":"3","key":"34614_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.lungcan.2011.05.001","volume":"74","author":"U Oleksiewicz","year":"2011","unstructured":"Oleksiewicz, U. et al. Neuroglobin and myoglobin in non-small cell lung cancer: Expression, regulation and prognosis. Lung Cancer 74(3), 411\u2013418 (2011).","journal-title":"Lung Cancer"},{"issue":"1","key":"34614_CR7","first-page":"49","volume":"9","author":"P Ruck","year":"1995","unstructured":"Ruck, P., Horny, H. P., Greschniok, A., Wehrmann, M. & Kaiserling, E. Nonspecific immunostaining of blast cells of acute leukemia by antibodies against nonhemopoietic antigens. Hematol. Pathol. 9(1), 49\u201356 (1995).","journal-title":"Hematol. Pathol."},{"issue":"8","key":"34614_CR8","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s11745-017-4272-z","volume":"52","author":"T Jue","year":"2017","unstructured":"Jue, T., Shih, L. & Chung, Y. Differential interaction of myoglobin with select fatty acids of carbon chain lengths C8 to C16. Lipids 52(8), 711\u2013727 (2017).","journal-title":"Lipids"},{"issue":"1","key":"34614_CR9","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.bbagen.2013.10.028","volume":"1840","author":"L Shih","year":"2014","unstructured":"Shih, L., Chung, Y., Sriram, R. & Jue, T. Palmitate interaction with physiological states of myoglobin. Biochim. Biophys. Acta 1840(1), 656\u2013666 (2014).","journal-title":"Biochim. Biophys. Acta"},{"issue":"25\u201326","key":"34614_CR10","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1016\/j.febslet.2008.09.047","volume":"582","author":"R Sriram","year":"2008","unstructured":"Sriram, R., Kreutzer, U., Shih, L. & Jue, T. Interaction of fatty acid with myoglobin. FEBS Lett. 582(25\u201326), 3643\u20133649 (2008).","journal-title":"FEBS Lett."},{"issue":"48","key":"34614_CR11","doi-asserted-by":"publisher","first-page":"25133","DOI":"10.1074\/jbc.M116.754978","volume":"291","author":"SV Chintapalli","year":"2016","unstructured":"Chintapalli, S. V. et al. Novel molecular interactions of acylcarnitines and fatty acids with myoglobin. J. Biol. Chem. 291(48), 25133\u201325143 (2016).","journal-title":"J. Biol. Chem."},{"issue":"10","key":"34614_CR12","doi-asserted-by":"publisher","first-page":"e0275725","DOI":"10.1371\/journal.pone.0275725","volume":"17","author":"J Armbruster","year":"2022","unstructured":"Armbruster, J. et al. Myoglobin regulates fatty acid trafficking and lipid metabolism in mammary epithelial cells. PLoS ONE 17(10), e0275725 (2022).","journal-title":"PLoS ONE"},{"issue":"12","key":"34614_CR13","doi-asserted-by":"publisher","first-page":"159026","DOI":"10.1016\/j.bbalip.2021.159026","volume":"1866","author":"MA Aboouf","year":"2021","unstructured":"Aboouf, M. A. et al. Myoglobin, expressed in brown adipose tissue of mice, regulates the content and activity of mitochondria and lipid droplets. Biochim. Biophys. Acta Mol. Cell Biol. Lipids. 1866(12), 159026 (2021).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids."},{"issue":"50","key":"34614_CR14","doi-asserted-by":"publisher","first-page":"43417","DOI":"10.1074\/jbc.M111.227553","volume":"286","author":"G Kristiansen","year":"2011","unstructured":"Kristiansen, G. et al. Endogenous myoglobin in breast cancer is hypoxia-inducible by alternative transcription and functions to impair mitochondrial activity: A role in tumor suppression?. J. Biol. Chem. 286(50), 43417\u201343428 (2011).","journal-title":"J. Biol. Chem."},{"issue":"2","key":"34614_CR15","first-page":"385","volume":"45","author":"A Bicker","year":"2020","unstructured":"Bicker, A. et al. The role of myoglobin in epithelial cancers: Insights from transcriptomics. Int. J. Mol. Med. 45(2), 385\u2013400 (2020).","journal-title":"Int. J. Mol. Med."},{"issue":"19","key":"34614_CR16","doi-asserted-by":"publisher","first-page":"11483","DOI":"10.3390\/ijms231911483","volume":"23","author":"MA Aboouf","year":"2022","unstructured":"Aboouf, M. A. et al. Pro-apoptotic and anti-invasive properties underscore the tumor-suppressing impact of myoglobin on a subset of human breast cancer cells. Int. J. Mol. Sci. 23(19), 11483 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"34614_CR17","doi-asserted-by":"publisher","first-page":"10495","DOI":"10.1073\/pnas.96.18.10495","volume":"96","author":"A G\u00f6decke","year":"1999","unstructured":"G\u00f6decke, A. et al. Disruption of myoglobin in mice induces multiple compensatory mechanisms. Proc. Natl. Acad. Sci. U. S. A. 96(18), 10495\u201310500 (1999).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt 4","key":"34614_CR18","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1099\/0022-1317-78-4-893","volume":"78","author":"W Qian","year":"1997","unstructured":"Qian, W. et al. Role of p53 mutation in polyomavirus-induced tumorigenesis. J. Gen. Virol. 78(Pt 4), 893\u2013903 (1997).","journal-title":"J. Gen. Virol."},{"issue":"3","key":"34614_CR19","first-page":"954","volume":"12","author":"CT Guy","year":"1992","unstructured":"Guy, C. T., Cardiff, R. D. & Muller, W. J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease. Mol. Cell Biol. 12(3), 954\u2013961 (1992).","journal-title":"Mol. Cell Biol."},{"issue":"4","key":"34614_CR20","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/ng747","volume":"29","author":"J Jonkers","year":"2001","unstructured":"Jonkers, J. et al. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat. Genet. 29(4), 418\u2013425 (2001).","journal-title":"Nat. Genet."},{"issue":"3","key":"34614_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41388-020-01560-0","volume":"40","author":"S Attalla","year":"2021","unstructured":"Attalla, S., Taifour, T., Bui, T. & Muller, W. Insights from transgenic mouse models of PyMT-induced breast cancer: Recapitulating human breast cancer progression in vivo. Oncogene 40(3), 475\u2013491 (2021).","journal-title":"Oncogene"},{"issue":"5","key":"34614_CR22","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/S0002-9440(10)63568-7","volume":"163","author":"EY Lin","year":"2003","unstructured":"Lin, E. Y. et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am. J. Pathol. 163(5), 2113\u20132126 (2003).","journal-title":"Am. J. Pathol."},{"issue":"6 Suppl","key":"34614_CR23","doi-asserted-by":"publisher","first-page":"7S","DOI":"10.1177\/0192623312454242","volume":"40","author":"D Rudmann","year":"2012","unstructured":"Rudmann, D. et al. Proliferative and nonproliferative lesions of the rat and mouse mammary, Zymbal\u2019s, preputial, and clitoral glands. Toxicol. Pathol. 40(6 Suppl), 7S-39S (2012).","journal-title":"Toxicol. Pathol."},{"issue":"3","key":"34614_CR24","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1128\/MMBR.00009-09","volume":"73","author":"MM Fluck","year":"2009","unstructured":"Fluck, M. M. & Schaffhausen, B. S. Lessons in signaling and tumorigenesis from polyomavirus middle T antigen. Microbiol. Mol. Biol. Rev. 73(3), 542\u2013563 (2009).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"34614_CR25","unstructured":"http:\/\/p53.free.fr\/Database\/Cancer_cell_lines\/NCI_60_cell_lines.html."},{"issue":"2","key":"34614_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41416-019-0642-z","volume":"122","author":"HM Becker","year":"2020","unstructured":"Becker, H. M. Carbonic anhydrase IX and acid transport in cancer. Br J Cancer. 122(2), 157\u2013167 (2020).","journal-title":"Br J Cancer."},{"issue":"3","key":"34614_CR27","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1186\/bcr2896","volume":"13","author":"G Kallergi","year":"2011","unstructured":"Kallergi, G. et al. Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients. Breast Cancer Res. 13(3), R59 (2011).","journal-title":"Breast Cancer Res."},{"key":"34614_CR28","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1007\/s002800051097","volume":"43","author":"DE Kleiner","year":"1999","unstructured":"Kleiner, D. E. & Stetler-Stevenson, W. G. Matrix metalloproteinases and metastasis. Cancer Chemother. Pharmacol. 43, S42\u2013S51 (1999).","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1\u20132","key":"34614_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1615\/CritRevOncog.v18.i1-2.40","volume":"18","author":"TN Seyfried","year":"2013","unstructured":"Seyfried, T. N. & Huysentruyt, L. C. On the origin of cancer metastasis. Crit. Rev. Oncog. 18(1\u20132), 43\u201373 (2013).","journal-title":"Crit. Rev. Oncog."},{"issue":"3","key":"34614_CR30","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1158\/0008-5472.CAN-07-2491","volume":"68","author":"KS Hoek","year":"2008","unstructured":"Hoek, K. S. et al. In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res. 68(3), 650\u2013656 (2008).","journal-title":"Cancer Res."},{"key":"34614_CR31","doi-asserted-by":"publisher","first-page":"8892300","DOI":"10.1155\/2020\/8892300","volume":"2020","author":"K Zhang","year":"2020","unstructured":"Zhang, K. et al. Molecular mechanism of stem cell differentiation into adipocytes and adipocyte differentiation of malignant tumor. Stem Cells Int. 2020, 8892300 (2020).","journal-title":"Stem Cells Int."},{"issue":"7","key":"34614_CR32","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.1074\/jbc.M306568200","volume":"279","author":"A Cartoni","year":"2004","unstructured":"Cartoni, A. et al. Oxidative degradation of cardiotoxic anticancer anthracyclines to phthalic acids. Novel function or ferrylmyoglobin. J. Biol. Chem. 279(7), 5088\u20135099 (2004).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"34614_CR33","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1124\/jpet.107.122820","volume":"322","author":"P Menna","year":"2007","unstructured":"Menna, P., Salvatorelli, E. & Minotti, G. Doxorubicin degradation in cardiomyocytes. J. Pharmacol. Exp. Ther. 322(1), 408\u2013419 (2007).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"34614_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/HP.S93413","volume":"3","author":"B Muz","year":"2015","unstructured":"Muz, B., de la Puente, P., Azab, F. & Azab, A. K. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia 3, 83\u201392 (2015).","journal-title":"Hypoxia"},{"issue":"11","key":"34614_CR35","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.tcb.2018.06.008","volume":"28","author":"AR Nobre","year":"2018","unstructured":"Nobre, A. R., Entenberg, D., Wang, Y., Condeelis, J. & Aguirre-Ghiso, J. A. The different routes to metastasis via hypoxia-regulated programs. Trends Cell Biol. 28(11), 941\u2013956 (2018).","journal-title":"Trends Cell Biol."},{"issue":"4","key":"34614_CR36","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/ijc.2910610422","volume":"61","author":"MW Gross","year":"1995","unstructured":"Gross, M. W., Karbach, U., Groebe, K., Franko, A. J. & Mueller-Klieser, W. Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids. Int. J. Cancer 61(4), 567\u2013573 (1995).","journal-title":"Int. J. Cancer"},{"issue":"36","key":"34614_CR37","doi-asserted-by":"publisher","first-page":"24204","DOI":"10.1074\/jbc.M109.006510","volume":"284","author":"T van den Beucken","year":"2009","unstructured":"van den Beucken, T. et al. Hypoxia-induced expression of carbonic anhydrase 9 is dependent on the unfolded protein response. J. Biol. Chem. 284(36), 24204\u201324212 (2009).","journal-title":"J. Biol. Chem."},{"issue":"4","key":"34614_CR38","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1158\/1078-0432.CCR-05-1269","volume":"12","author":"Y Nakamura","year":"2006","unstructured":"Nakamura, Y. et al. Nitric oxide in breast cancer: Induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis. Clin. Cancer Res. 12(4), 1201\u20131207 (2006).","journal-title":"Clin. Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34614-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34614-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34614-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T12:15:49Z","timestamp":1683720949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34614-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["34614"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-34614-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"assertion":[{"value":"3 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7530"}}